LY-2955303

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameLY-2955303
Drug Alias NameLY-2955303
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1]  N/A
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A